cathepsin B inhibitors (Axys)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namecathepsin B inhibitors (Axys)
Drug Alias Namecathepsin B inhibitors (Arris)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCathepsin B inhibitors
TargetsCathepsin B
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArris Pharmaceutical Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArris Pharmaceutical CorpCelera
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A